{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T07:12:30Z","timestamp":1765177950458,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00957","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:41:28Z","timestamp":1568076088000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Myasthenia Gravis With Reversible Pyramidal Tract Damage and Pseudo Internuclear Ophthalmoplegia. A Case Report and Literature Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Yinghong","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghe","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1212\/WNL.0000000000005323","article-title":"Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis","volume":"90","author":"Hewett","year":"2018","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nmd.2017.01.020","article-title":"Association of early onset myasthenia gravis in Newfoundland dogs with the canine major histocompatibility complex class I","volume":"27","author":"Wolf","year":"2017","journal-title":"Neuromusc Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mus.26114","article-title":"Burden of illness in patients with treatment refractory myasthenia gravis","volume":"2","author":"Engel-Nitz","year":"2018","journal-title":"Muscle Nerve"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-35951-4_1214-1","article-title":"Internuclear ophthalmoplegia","author":"Puckett","year":"2015","journal-title":"Encyclopedia Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000276922","article-title":"Bilateral pseudo-internuclear ophthalmoplegia in myasthenia gravis","volume":"59","author":"Ito","year":"1997","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"B7","doi-asserted-by":"publisher","first-page":"291731","DOI":"10.1155\/2011\/291731","article-title":"Myasthenia gravis development and crisis subsequent to multiple sclerosis","volume":"2011","author":"Gharagozli","year":"2011","journal-title":"Case Rep Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1191\/1352458503ms964oa","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia","volume":"9","author":"Isbister","year":"2003","journal-title":"Mult Scler"},{"key":"B9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflamm"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/archneurol.2011.200","article-title":"Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?","volume":"68","author":"Vaknindembinsky","year":"2011","journal-title":"Arch Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"bcr2014207362","DOI":"10.1136\/bcr-2014-207362","article-title":"Neuromyelitis optica and myasthenia gravis in a young Nigerian girl","volume":"2015","author":"Balarabe","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000334128","article-title":"Myasthenia gravis during the course of neuromyelitis optica","volume":"3","author":"Etemadifar","year":"2011","journal-title":"Case Rep Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Digest World Core Med J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.slsci.2016.02.144","article-title":"Sleep disorders in patients with myasthenia gravis: a systematic review","volume":"8","author":"Oliveira","year":"2015","journal-title":"Sleep Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0972-2327.156560","article-title":"Association between myasthenia gravis and cognitive function: a systematic review and meta-analysis","volume":"18","author":"Mao","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbacli.2015.04.003","article-title":"Cognitive impairment as a central cholinergic deficit in patients with myasthenia gravis","volume":"3","author":"Kaltsatou","year":"2015","journal-title":"BBA Clin"},{"key":"B18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0960-8966(99)00013-9","article-title":"Myasthenia gravis and peripheral neuropathy in an Amazon indigenous female","volume":"9","author":"Dias-Tosta","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1172\/JCI200318180","article-title":"Autonomic \u201cmyasthenia\u201d: the case for an autoimmune pathogenesis","volume":"111","author":"Drachman","year":"2003","journal-title":"J Clin Investig."},{"key":"B21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/pgmj.67.788.590-a","article-title":"Myasthenia gravis and reversible pyramidal tract signs in a thyrotoxic patient","volume":"67","author":"Sharma","year":"1991","journal-title":"Postgrad Med J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3969\/j.issn.1006-2963.2005.04.018","article-title":"Myasthenia gravis with pyramidal tract sign: a case report","volume":"12","author":"Pang","year":"2005","journal-title":"Chin J Neuroimmunol Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/archopht.1966.00970050365009","article-title":"Myasthenic pseudo-internuclear ophthalmoplegia","volume":"75","author":"Glaser","year":"1966","journal-title":"Arch Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"bcr201320323","DOI":"10.1136\/bcr-2013-203234","article-title":"Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis","volume":"2014","author":"Nijsse","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0002-9394(79)90627-5","article-title":"Ocular myasthenia gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia","volume":"88","author":"Acers","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00415-007-0591-y","article-title":"Ocular myasthenia revisited: Insights from pseudo-internuclear ophthalmoplegia","volume":"254","author":"Khanna","year":"2007","journal-title":"J Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(77)91506-9","article-title":"Acetylcholine-receptor antibodies in cerebrospinal fluid of patients with myasthenia gravis","volume":"310","author":"Lefvert","year":"1977","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0404.1990.tb00977.x","article-title":"Oligoclonal immunoglobulin G in cerebrospinal fluid of myasthenia gravis patients","volume":"81","author":"Mavra","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"B29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1749-6632.1981.tb33780.x","article-title":"Central nervous system involvement in myasthenia gravis","volume":"377","author":"Bergonzi","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"B30","first-page":"368","article-title":"Systemic manifestations of myasthenia gravis and its putative pathogenesis","volume":"36","author":"Zhang","year":"1997","journal-title":"Chin J Intern Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:41:32Z","timestamp":1568076092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":31,"alternative-id":["10.3389\/fneur.2019.00957"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00957","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"article-number":"957"}}